Shigeto Fuse

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Tohru Kobayashi, Tsutomu Saji, Tetsuya Otani et al. · The Lancet · 2012 · 674 citations

Medicine, Cardiology, Pharmacotherapy +11

A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population

Tohru Kobayashi, Shigeto Fuse, Naoko Sakamoto et al. · Journal of the American Society of Echocardiography · 2016 · 247 citations

Medicine, Cardiology, Pediatrics +11

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events

Masaru Miura, Tohru Kobayashi, Tetsuji Kaneko et al. · JAMA Pediatrics · 2018 · 148 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Coronary artery outcomes among children with Kawasaki disease in the United States and Japan

Shohei Ogata, Adriana H. Tremoulet, Yuichiro Sato et al. · International Journal of Cardiology · 2013 · 109 citations · Full text

Medicine, Cardiology, Pediatrics +11